Because a single biomarker will not provide information regarding both tissue type and malignant transformation throughout the various stages of tumor development and progression, we further combined tissue hnRNP K intensity and serum AFP concentration to form a biomarker panel. The gene discussed is HNRNPK; the disease is neoplasm.